FDA expands use of breast cancer drug Kisqali

Women with early stage breast cancer may now take Kisqali, a medication already approved for advanced disease, following the U.S. Food and Drug Administration’s expanded approval of the treatment, drug maker Novartis announced Tuesday.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup